NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effectToshiki Etani, Satoru Takahashi|Oncotarget|2014Cited by 46
NCL1, A Highly Selective Lysine-Specific Demethylase 1 Inhibitor, Suppresses Castration-Resistant Prostate Cancer Growth via Regulation of Apoptosis and AutophagyToshiki Etani, Satoru Takahashi|Journal of Clinical Medicine|2019Cited by 27